DelSite Biotechnologies, Inc. (OTC BB: DSII)

DelSite Biotechnologies, Inc. (OTC BB: DSII), an ISO 9001-certified, research-based, biopharmaceutical and consumer products company, has a core technology based on naturally-occurring complex carbohydrates. The company is focused on manufacturing and marketing consumer products as well as manufacturing quality products for other companies. Its proprietary GelSite(r) technology is protected by more than 130 patents in 26 countries. For further information, visit the Company’s web site at www.delsite.com.